October 21, 2024
Trending Now
1
FDA Approves First Home COVID-19/Flu Combo Test
2
Study: 65.8% of Men with Diabetes Experience Erectile Dysfunction
3
Are Millions of Aging Americans Facing Dementia Alone?
4
Surgery Complications Deadlier for Women, Study Finds
5
NDA Resubmitted for Reproxalap
6
First U.S. Dental Practice Certified as Autism Center
Conference Coverage
Euretina 2024
SOHO 2024
October 14, 2024
New Directions in ALL, CML, and CLL Treatment
ESMO Congress 2024
Clinical Guidelines
View MoreOctober 21, 2024
Societies Update Stroke Prevention Strategy
October 15, 2024
Does Teen Cannabis Use Harm Grades and School?
October 15, 2024
EULAR Develops Classification Criteria for Hand OA
October 15, 2024
New SLE Treatments Show Promise in Trials
Commentary & Perspectives
View MoreOctober 18, 2024
Helene, CVS Hit 25,000 Patients Dependent on IV Nutrition
October 15, 2024
Are Millions of Aging Americans Facing Dementia Alone?
October 15, 2024
New SLE Treatments Show Promise in Trials
October 15, 2024
Alien Milling, 3Shape Unveil Short Film “Molar City”
FDA & Government News
View MoreOctober 21, 2024
Botox Expands Below the Face: FDA Nod
October 21, 2024
Oral Diabetes Drug Lowers Heart Risks by 14%: Study
October 21, 2024
Doctors, Nurses Among 47 Charged in Newborn Death Case
October 18, 2024
FDA Approves Gastric Cancer Therapy
Business Management
View MoreOctober 01, 2024
Win the Battle for Positive Change
October 01, 2024
Viewpoint From the Editor: Another Year Almost Over – How Did We Do?
October 01, 2024